QIAGEN N.V.: BlackRock Reports 12.90% Voting Rights
QIAGEN N.V. disclosed an AFM notice stating that BlackRock, Inc., through various entities, held an 11.51% capital interest and a 12.90% voting rights stake in QIAGEN as of September 29, 2026.
QIAGEN N.V. disclosed an AFM notice stating that BlackRock, Inc., through various entities, held an 11.51% capital interest and a 12.90% voting rights stake in QIAGEN as of September 29, 2026.